De-escalation to ticagrelor 60 mg at day 30
2023/01
Phase 3 small_molecule active
Quick answer
De-escalation to ticagrelor 60 mg at day 30 for Non ST Segment Elevation Acute Coronary Syndrome is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Non ST Segment Elevation Acute Coronary Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active